These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 21256571

  • 1. National community prevalence of overactive bladder in the United States stratified by sex and age.
    Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I.
    Urology; 2011 May; 77(5):1081-7. PubMed ID: 21256571
    [Abstract] [Full Text] [Related]

  • 2. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K, EPIC Study Group.
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE, Milsom I, Kopp Z, Abrams P, Artibani W, Herschorn S.
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study.
    Vaughan CP, Johnson TM, Ala-Lipasti MA, Cartwright R, Tammela TL, Taari K, Auvinen A, Tikkinen KA.
    Eur Urol; 2011 Apr; 59(4):629-36. PubMed ID: 21306820
    [Abstract] [Full Text] [Related]

  • 10. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I.
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [Abstract] [Full Text] [Related]

  • 11. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL, Molander U, Fall M, Edlund C, Peeker R, Milsom I.
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD, Kaufman JM, Sand PK, Smith N, Andoh M.
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An epidemiological survey of overactive bladder symptoms in Japan.
    Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society Committee.
    BJU Int; 2005 Dec; 96(9):1314-8. PubMed ID: 16287452
    [Abstract] [Full Text] [Related]

  • 16. Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study.
    Coyne KS, Margolis MK, Kopp ZS, Kaplan SA.
    Urology; 2012 Jan; 79(1):95-101. PubMed ID: 22055692
    [Abstract] [Full Text] [Related]

  • 17. Urinary incontinence and overactive bladder in patients with heart failure.
    Palmer MH, Hardin SR, Behrend C, Collins SK, Madigan CK, Carlson JR.
    J Urol; 2009 Jul; 182(1):196-202. PubMed ID: 19447424
    [Abstract] [Full Text] [Related]

  • 18. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.
    Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P.
    Eur Urol; 2006 Dec; 50(6):1306-14; discussion 1314-5. PubMed ID: 17049716
    [Abstract] [Full Text] [Related]

  • 19. Predictors of discontinuing overactive bladder medications.
    Brubaker L, Fanning K, Goldberg EL, Benner JS, Trocio JN, Bavendam T, Jumadilova Z.
    BJU Int; 2010 May; 105(9):1283-90. PubMed ID: 19912189
    [Abstract] [Full Text] [Related]

  • 20. Overactive bladder symptoms, stress urinary incontinence and associated bother in women aged 40 and above; a Belgian epidemiological survey.
    de Ridder D, Roumeguère T, Kaufman L.
    Int J Clin Pract; 2013 Mar; 67(3):198-204. PubMed ID: 23409688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.